Клинические испытания препаратов пролонгированного действия и супрамолекулярного комплекса
Închide
Articolul precedent
Articolul urmator
546 1
Ultima descărcare din IBN:
2022-08-19 12:21
SM ISO690:2012
ЕНГАШЕВА, Екатерина. Клинические испытания препаратов пролонгированного действия и супрамолекулярного комплекса. In: Actual problems of zoology and parasitology: achievements and prospects, 13 octombrie 2017, Chișinău. Chișinău, Republica Moldova: Institutul de Zoologie, 2017, pp. 77-84. ISBN 978-9975-66-590-2. DOI: https://doi.org/10.53937/9789975665902.11
EXPORT metadate:
Google Scholar
Crossref
CERIF

DataCite
Dublin Core
Actual problems of zoology and parasitology: achievements and prospects 2017
Simpozionul "Actual problems of zoology and parasitology: achievements and prospects"
Chișinău, Moldova, 13 octombrie 2017

Клинические испытания препаратов пролонгированного действия и супрамолекулярного комплекса

DOI: https://doi.org/10.53937/9789975665902.11

Pag. 77-84

Енгашева Екатерина
 
ООО ≪НВЦ Агроветзащита≫, г. Москва
 
Disponibil în IBN: 14 septembrie 2018


Rezumat

Testing of ivermectin-based drugs Iverlong 1 and Iverlong 2, with various prolongators for helminthiases and arachnoentomoses, has demonstrated the efficacy of 95 to 100%. The effective drug duration was 75 days. Clinical testing of the supramolecular complex Niclomec has demonstrated 100% efficacy in laboratory animals infected with trichinella and cestodes. The efficacy was 97 to 100% in sheep spontaneously infected with digestive-tract strongyles and moniezia.

Cuvinte-cheie
Iverlong 1, Iverlong 2, Niclomec,

sheep, mice